Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate
- PMID: 29869770
- DOI: 10.1007/s12149-018-1253-0
Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate
Abstract
Aim: To assess the predictive and prognostic value of textural parameters in locally advanced breast cancer (LABC) obtained by 18F-FDG PET/CT.
Methods: Prospective study including 68 patients with LABC, neoadjuvant chemotherapy (NC) indication and a baseline 18F-FDG PET/CT. Breast specimens were grouped into molecular phenotypes and classified as responders or non-responders after completion of NC. Patients underwent standard follow-up to obtain the disease-free survival (DFS) and overall survival (OS). After breast tumor segmentation, three-dimensional (3D) textural measures were computed based on run-length matrices (RLM) and co-occurrence matrices (CM). Relations between textural features with risk categories attending to molecular phenotypes were explored. Kaplan-Meier analysis and univariate and multivariate Cox proportional hazard analysis were used to study the potential of textural variables, molecular phenotypes and histologic response to predict DFS and OS. Receiver operating characteristic (ROC) analysis was used to obtain the best cut-off value, the area under the curve (AUC) and sensitivity and specificity considering OS and DFS.
Results: Eighteen patients were classified as responders. Mean ± SD of DFS and OS was 70.87 ± 21.85 and 76.77 ± 18.80 months, respectively. Long run emphasis (LRE) and long run high gray-level emphasis (LRHGE) showed a relation with risk categories. Low gray-level run emphasis (LGRE), LRHGE and run-length non-uniformity (RLNU) showed association with the NC response. Textural variables were significantly associated with OS and DFS in univariate analysis. Regarding the multivariate Cox regression analysis, PET stage with short run high gray-level emphasis (SRHGE) was significantly associated with OS, and PET stage and high gray-level run emphasis (HGRE) with DFS.
Conclusion: Textural variables obtained with 18F-FDG PET/CT were predictors of neoadjuvant chemotherapy response and prognosis, being as relevant as PET stage at diagnosis for OS and DFS prediction.
Keywords: 18F-FDG PET/CT; Breast cancer; Disease-free survival; Neoadjuvant chemotherapy response; Overall survival; Textural features.
Similar articles
-
Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):73-79. doi: 10.1016/j.remn.2017.09.002. Epub 2017 Nov 2. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 29102649 Clinical Trial. English, Spanish.
-
Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer.Clin Nucl Med. 2016 Jul;41(7):e313-22. doi: 10.1097/RLU.0000000000001191. Clin Nucl Med. 2016. PMID: 26953659
-
Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.Ann Nucl Med. 2017 Dec;31(10):726-735. doi: 10.1007/s12149-017-1203-2. Epub 2017 Sep 8. Ann Nucl Med. 2017. PMID: 28887761 Free PMC article.
-
Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.Breast Cancer Res. 2020 Oct 31;22(1):119. doi: 10.1186/s13058-020-01350-2. Breast Cancer Res. 2020. PMID: 33129348 Free PMC article.
-
¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.Eur J Nucl Med Mol Imaging. 2016 May;43(5):983-993. doi: 10.1007/s00259-015-3295-z. Epub 2016 Jan 13. Eur J Nucl Med Mol Imaging. 2016. PMID: 26758726 Review.
Cited by
-
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer.EJNMMI Res. 2024 Jul 4;14(1):60. doi: 10.1186/s13550-024-01115-4. EJNMMI Res. 2024. PMID: 38965124 Free PMC article.
-
FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma.Diagnostics (Basel). 2022 Mar 12;12(3):694. doi: 10.3390/diagnostics12030694. Diagnostics (Basel). 2022. PMID: 35328247 Free PMC article.
-
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1468-1477. doi: 10.1007/s00259-019-04313-8. Epub 2019 Mar 26. Eur J Nucl Med Mol Imaging. 2019. PMID: 30915523
-
A Systematic Review of PET Textural Analysis and Radiomics in Cancer.Diagnostics (Basel). 2021 Feb 23;11(2):380. doi: 10.3390/diagnostics11020380. Diagnostics (Basel). 2021. PMID: 33672285 Free PMC article. Review.
-
Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [18F]FDG PET/CT in Early Triple-Negative Breast Cancer.Cancers (Basel). 2022 Jan 27;14(3):637. doi: 10.3390/cancers14030637. Cancers (Basel). 2022. PMID: 35158904 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical